Home · Health · Oct 25 archive

FSSAI Issues Alert on Baby Foods Amid Global Concerns

Confirmed

Health Desk

In Short: The Food Safety and Standards Authority of India (FSSAI) has issued an alert on infant formula after a sample failed biotin requirements, raising concerns about nutritional quality and contamination.

Flag of India
Flag of India (Wikimedia Commons)

In September 2026, FSSAI found that a sample of follow-up formula did not meet prescribed biotin (Vitamin B7) requirements on re-analysis, according to a recent report by The Indian Express.

Biotin is crucial for processing fats, carbohydrates, and proteins, and its deficiency can affect a baby's rapid growth and development.

The alert comes amid renewed global concerns about infant formula safety, following investigations and recalls in the US involving potential microbial contamination and testing for heavy metals, pesticides, and other chemical contaminants.

Parents concerned about product quality are advised to consult their pediatricians rather than making independent feeding changes.

The FSSAI has also invoked Section 3 of the Infant Milk Substitutes, Feeding Bottles and Infant Foods Act, 1992, which restricts advertising and promotion of infant milk substitutes and specified infant foods.

The authority examined Nestlé's infant nutrition products and their promotional material available on e-commerce platforms, finding non-compliance with regulatory standards.

In one case, FSSAI flagged promotional claims regarding '5 HMOs' (Human Milk Oligosaccharides) and 'Whey Protein' on NAN Excella Pro Stage 1.

Contamination cannot always be detected by looking at a product or reading its label, highlighting the need for rigorous testing and regulatory oversight.

The issue has taken on added relevance in India, where concerns about infant formula safety are growing.

In the UK, residents near a major chemical factory are facing high levels of cancer-causing chemicals in their blood, leading to potential legal action against the factory.

In the US, Abbott Laboratories will pay $385 million to resolve claims tied to an investigation of contamination at a baby formula factory in Sturgis, Michigan, which led to supply shortages in 2022.

According to research, an estimated 2,854 locations in the U.S. have documented some PFAS contamination, but not all exceed health advisory levels.

What this adds

The FSSAI's alert highlights the importance of regulatory oversight in ensuring the safety and nutritional quality of infant formula products.

What's confirmed

What's still developing

Sources